Wissenschaftliche Arbeiten

Uzm. Dr. Umut Bakay

31 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Upadacitinib in Rheumatoid Arthritis After Prior TNF Inhibitor Failure: A 12-Month Multicenter Real-World Study

    Journal of Clinical Practice and Research, 2026

    DOI 10.14744/cpr.2026.21047 PMID 42676558 Frei zugänglicher VolltextQuelle: OpenAlex

  2. Comment on: "Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort study"

    Rheumatology and immunology research, 2026

    DOI 10.1515/rir-2026-0009 PMID 41969818 Frei zugänglicher VolltextQuelle: Europe PMC

  3. Preliminary Validation of the Early Sacroiliitis Screening Tool (ESHST) for Identifying Hidradenitis Suppurativa Patients at High Risk of Spondyloarthritis

    International journal of dermatology, 2026

    DOI 10.1111/ijd.70563 PMID 42381196 Frei zugänglicher VolltextQuelle: Europe PMC

  4. Comment on: Impact of early immuno-suppressive therapy on pulmonary arterial hypertension in systemic sclerosis: a multicentre real-world study

    Clinical and Experimental Rheumatology, 2026

    DOI 10.55563/clinexprheumatol/tb4bnv PMID 41568444 Frei zugänglicher VolltextQuelle: OpenAlex

  5. Right ventriculoarterial coupling as a marker of subclinical myocardial damage in rheumatoid arthritis: Comments on the study by Miranda-Aquino et al.

    Reumatología Clínica, 2026

    DOI 10.1016/j.reuma.2025.502044 Quelle: OpenAlex

  6. Letter to the Editor: IgG4-Related Orbital Disease from a Rheumatologist’s Perspective

    OSMANGAZİ JOURNAL OF MEDICINE, 2026

    DOI 10.20515/otd.1806503 Frei zugänglicher VolltextQuelle: OpenAlex

  7. Right ventriculoarterial coupling as a marker of subclinical myocardial damage in rheumatoid arthritis: Comments on the study by Miranda-Aquino et al.

    Reumatología Clínica (English Edition), 2026

    DOI 10.1016/j.reumae.2026.502044 PMID 41786374 Quelle: OpenAlex

  8. Could microRNA-146a and microRNA-223 serve as biomarkers for predicting disease activity in rheumatoid arthritis patients?

    The Annals of Clinical and Analytical Medicine, 2026

    DOI 10.4328/acam.22719 Frei zugänglicher VolltextQuelle: OpenAlex

  9. Sicca severity in primary Sjögren’s disease reflects symptom amplification rather than systemic inflammatory activity

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1846576 Frei zugänglicher VolltextQuelle: OpenAlex

  10. Diagnostic accuracy and clinical utility of the EARP questionnaire for detecting early psoriatic arthritis: a Turkish multicenter validation study

    Reumatologia/Rheumatology, 2026

    DOI 10.5114/reum/217124 Frei zugänglicher VolltextQuelle: OpenAlex

  11. Minor salivary gland biopsy in clinically suspected Sjögren's disease: still indispensable for seronegative cases?

    Zeitschrift fur Rheumatologie, 2025

    DOI 10.1007/s00393-025-01746-5 PMID 41168553 1 Zitation (Europe PMC) Quelle: Europe PMC

  12. Unveiling a spondyloarthritis-like phenotype in Sjögren's disease : clinical, serological, and radiological correlates of sacroiliitis in a real-world cohort

    Expert review of clinical immunology, 2025

    DOI 10.1080/1744666x.2025.2577669 PMID 41108553 Quelle: Europe PMC

  13. Comment on: "nociplastic pain in axial spondyloarthritis and psoriatic arthritis: role of JAK kinases in immunopathology and therapeutic impact of JAK inhibitors" by Horbal and Maksymowych

    Expert review of clinical immunology, 2025

    DOI 10.1080/1744666x.2025.2605306 PMID 41390945 Quelle: Europe PMC

  14. Comment on: "Association of MUC5B Promoter Variant With Interstitial Lung Disease in Systemic Sclerosis"

    International journal of rheumatic diseases, 2025

    DOI 10.1111/1756-185x.70474 PMID 41235719 Quelle: Europe PMC

  15. Hepatic Safety of IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis: A 12-Month Retrospective Cohort Evaluation Using the FIB-4 Index

    Dermatology Practical & Conceptual, 2025

    DOI 10.5826/dpc.1601a6746 PMID 41912199 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  16. A window into the vascular endothelium in COVID-19: Nails

    Dermatology Practical & Conceptual, 2025

    DOI 10.5826/dpc.1501a4927 PMID 39853249 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  17. Real-World Effectiveness and Safety of Upadacitinib in Tumor Necrosis FactorInhibitor Refractory Axial Spondyloarthritis: 52-Week Outcomes from a Single-Center Cohort

    Archives of Rheumatology, 2025

    DOI 10.5152/archrheumatol.2025.11098 PMID 41578768 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  18. Subclinical Spondyloarthritis Features in Patients with Hidradenitis Suppurativa: A Real-World Cross-Sectional Analysis

    Journal of Clinical Practice and Research, 2025

    DOI 10.14744/cpr.2025.87060 PMID 41347191 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  19. Upadacitinib in psoriatic arthritis with prior TNF-inhibitor failure: a 56-week real-world study

    Clinical and Experimental Rheumatology, 2025

    DOI 10.55563/clinexprheumatol/gniy9i PMID 41231514 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  20. ABS0948 COULD microRNA-146a AND microRNA-223 SERVE AS BIOMARKERS FOR PREDICTING DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.1627 Frei zugänglicher VolltextQuelle: OpenAlex

  21. POS0488 AI-POWERED SCREENING FOR PSORIATIC ARTHRITIS: A COMPARATIVE STUDY WITH EXISTING TOOLS

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.05.870 Frei zugänglicher VolltextQuelle: OpenAlex

  22. Olgular Eşliğinde Genel Dahiliye II

    Akademisyen Kitabevi eBooks, 2025

    DOI 10.37609/akya.94 Frei zugänglicher VolltextQuelle: OpenAlex

  23. Antı-Tnf Dirençli Aksiyel Spondiloartrit ve Vitiligo Birlikteliğinde Upadacitinib ile Tam Remisyon

    Akademisyen Kitabevi eBooks, 2025

    DOI 10.37609/akya.94.c1578 Frei zugänglicher VolltextQuelle: OpenAlex

  24. Comment on: “Comprehensive analysis of patients with rheumatoid arthritis-associated interstitial lung disease” by Kim et al.

    The Korean Journal of Internal Medicine, 2025

    DOI 10.3904/kjim.2025.316 PMID 41430210 Frei zugänglicher VolltextQuelle: OpenAlex

  25. Comment on “Real-world efficacy and retention of guselkumab in psoriatic arthritis: a 12-month multicenter study

    ARP Rheumatology, 2025

    DOI 10.63032/jkur6010 PMID 41480890 Frei zugänglicher VolltextQuelle: OpenAlex

  26. IgG4 İlişkili Orbital Hastalık: Romatoloji Perspektifinden Editöre Mektup

    DergiPark (Istanbul University), 2025

    Quelle: OpenAlex

  27. Do Disease Parameters Related to Primary Sjögren's Syndrome have an Impact on the Severity of Co-Existing Fibromyalgia Syndrome or Vice Versa?

    Aktuelle Rheumatologie, 2024

    DOI 10.1055/a-2334-6194 Quelle: OpenAlex

  28. Could cognitive impairment manifest in Behçet's disease even in the absence of neurological symptoms?

    Pamukkale Medical Journal, 2024

    DOI 10.31362/patd.1584077 Frei zugänglicher VolltextQuelle: ORCID

  29. A case of certolizumab-induced purpura annularis telangiectodes of Majocchi and literature review

    International journal of rheumatic diseases, 2024

    DOI 10.1111/1756-185x.14854 PMID 37522716 1 Zitation (Europe PMC) Quelle: Europe PMC

  30. Asemptomatik hiperüriseminin hidradenitis süppürativa hastalık seyrine etkileri

    Turkish Journal of Clinics and Laboratory, 2024

    DOI 10.18663/tjcl.1529053 Frei zugänglicher VolltextQuelle: OpenAlex

  31. Romatoid artrit'te mikrorna-146A, mikrorna-223 düzeyleri, sensitive ve spesifiteleri, diğer hastalık parametreleri ve biyolojik ajan tedavisiyle ilişkisi / Serum microrna-146A and mi?crorna-223 levels, sensitivity and specificitys, relationship with disease parameters and treatment of biological agents in rheumatoid arthritis

    DSpace - FIRAT (Fırat University), 2016

    Frei zugänglicher VolltextQuelle: OpenAlex